138 related articles for article (PubMed ID: 18833056)
1. Papulo-pustular eruption during cetuximab treatment.
Satta R; Cuccuru MA; Pirodda C; Cottoni F
G Ital Dermatol Venereol; 2008 Feb; 143(1):87-8. PubMed ID: 18833056
[No Abstract] [Full Text] [Related]
2. Images in clinical medicine. Cetuximab-associated acneiform eruption.
Moss JE; Burtness B
N Engl J Med; 2005 Nov; 353(19):e17. PubMed ID: 16282170
[No Abstract] [Full Text] [Related]
3. Rosaceiform eruption induced by cetuximab.
Fernández-Torres R; Martínez Gomez W; Cuevas Santos J; Paradela S; Fonseca Capdevila E
Eur J Dermatol; 2010; 20(3):392-3. PubMed ID: 20172848
[No Abstract] [Full Text] [Related]
4. [Erlotinib-induced acneiform rash not affecting previously irradiated skin].
Eguren C; Domínguez-Fernández I; Santiago-Sánchez-Mateos DI; García-Díez A
Actas Dermosifiliogr; 2010 Mar; 101(2):186-7. PubMed ID: 20223168
[No Abstract] [Full Text] [Related]
5. Two cases of acneiform eruption induced by inhibitor of epidermal growth factor receptor.
Gencoglan G; Ceylan C
Skin Pharmacol Physiol; 2007; 20(5):260-2. PubMed ID: 17641540
[TBL] [Abstract][Full Text] [Related]
6. Severe acneiform rash.
Yamamoto DS; Viale PH; Zhao G
Clin J Oncol Nurs; 2004 Dec; 8(6):654-6. PubMed ID: 15637959
[No Abstract] [Full Text] [Related]
7. Cetuximab-induced acneiform eruption and the response to isotretinoin.
Vezzoli P; Marzano AV; Onida F; Alessi E; Galassi B; Tomirotti M; Berti E
Acta Derm Venereol; 2008; 88(1):84-6. PubMed ID: 18176767
[No Abstract] [Full Text] [Related]
8. [Acneiform eruptions induced by cetuximab].
Walon L; Gilbeau C; Lachapelle JM
Ann Dermatol Venereol; 2003 Apr; 130(4):443-6. PubMed ID: 12843857
[TBL] [Abstract][Full Text] [Related]
9. [Contribution to acneiform eruptions by epidermal growth factor receptor inhibitors].
Bodet D; Bartralot R; Mollet J; Heras C; García-Patos V
Actas Dermosifiliogr; 2006 Mar; 97(2):148-9. PubMed ID: 16595122
[No Abstract] [Full Text] [Related]
10. Severe acneiform eruption induced by cetuximab (Erbitux).
Lee JE; Lee SJ; Lee HJ; Lee JH; Lee KH
Yonsei Med J; 2008 Oct; 49(5):851-2. PubMed ID: 18972607
[TBL] [Abstract][Full Text] [Related]
11. [Topical steroids in the treatment of paronychia induced by the epidermal growth factor receptor inhibitor cetuximab].
Coquart N; Karam A; Metges JP; Misery L
Ann Dermatol Venereol; 2010 Apr; 137(4):306-7. PubMed ID: 20417368
[No Abstract] [Full Text] [Related]
12. Grover's disease induced by cetuximab.
Tscharner GG; Bühler S; Borner M; Hunziker T
Dermatology; 2006; 213(1):37-9. PubMed ID: 16778425
[TBL] [Abstract][Full Text] [Related]
13. Facial acneiform rash associated with sorafenib.
Fleta-Asín B; Vañó-Galván S; Ledo-Rodríguez A; Truchuelo-Díez M; Jaén-Olasolo P
Dermatol Online J; 2009 Apr; 15(4):7. PubMed ID: 19450400
[TBL] [Abstract][Full Text] [Related]
14. Follicular drug eruption induced by gefitinib (ZD 1839, iressa): clinical picture correlates with in vitro data of focal epidermal necrosis after epidermal growth factor inhibition in skin cultures.
Treudler R; Zouboulis CC
Dermatology; 2005; 211(4):375-6. PubMed ID: 16286753
[No Abstract] [Full Text] [Related]
15. [Acneiform eruption secondary to cetuximab with pseudomalignant histopathological changes].
Vidal-Olmo I; Bassas-Vila J; Herrera-Acosta E; Umbert-Millet P
Actas Dermosifiliogr; 2008 Mar; 99(2):159-60. PubMed ID: 18346444
[No Abstract] [Full Text] [Related]
16. Cetuximab-induced cutaneous toxicity.
Tomková H; Kohoutek M; Zábojníková M; Pospísková M; Ostrízková L; Gharibyar M
J Eur Acad Dermatol Venereol; 2010 Jun; 24(6):692-6. PubMed ID: 19925598
[TBL] [Abstract][Full Text] [Related]
17. Malassezia folliculitis presented as acneiform eruption after cetuximab administration.
Cholongitas E; Pipili C; Ioannidou D
J Drugs Dermatol; 2009 Mar; 8(3):274-5. PubMed ID: 19271376
[TBL] [Abstract][Full Text] [Related]
18. [Unilateral acneiform rash in facial palsy].
Kerob D; Hennequin V; Bousquet G; Behm E; Lebbe C
Ann Dermatol Venereol; 2010 Nov; 137(11):727-9. PubMed ID: 21074658
[TBL] [Abstract][Full Text] [Related]
19. Acneiform eruption induced by epidermal growth factor receptor inhibitors in patients with solid tumours.
Jacot W; Bessis D; Jorda E; Ychou M; Fabbro M; Pujol JL; Guillot B
Br J Dermatol; 2004 Jul; 151(1):238-41. PubMed ID: 15270903
[No Abstract] [Full Text] [Related]
20. Randomized double-blind trial of prophylactic oral minocycline and topical tazarotene for cetuximab-associated acne-like eruption.
Scope A; Agero AL; Dusza SW; Myskowski PL; Lieb JA; Saltz L; Kemeny NE; Halpern AC
J Clin Oncol; 2007 Dec; 25(34):5390-6. PubMed ID: 18048820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
